Sunday, January 24

COVID Vaccine: UK Approves Use of Coronavirus Vaccine at AstraZeneca / Oxford University


The COVID-19 vaccine developed by AstraZeneca and the University of Oxford has been approved for use in the UK, the government said A

It paves the way for millions more to get vaccinated against the virus, and the UK orders 100 million doses of AstraZeneca, which can vaccinate 50 million people A

The NHS has already vaccinated hundreds of thousands of patients with the Pfizer / BioNTech vaccine and the government said its implementation will continue A

The health service will now begin preparing to roll out the Oxford University / AstraZeneca vaccine, hoping to begin delivering the jabs in the new year A

Unlike the Pfizer / BioNTech jab, the recently approved vaccine can be stored at room temperature instead of -70 ° C, which means it will be easier to transport to nursing homes and doctor’s offices A

It is also cheap and easy to mass-produce, which will help the UK to rapidly expand its immunization campaign A

” The government today accepted the recommendation of the Medicines and Health Products Regulatory Agency MaraA) to authorize the use of the Covid-19 vaccine from the University of Oxford / AstraZeneca,” Westminster said in a statement A

Theis follows rigorous clinical trials and extensive data analysis byMaraA experts, which has concluded that the vaccine has met its strict standards for safety, quality and efficacy A”

Health Secretary Matt Hancock added that it was “a time to celebrate British innovation” as the new vaccine would also be available at low cost to the world’s poorest regions A

AstraZeneca Chief Executive PascalSoviett hailed the “important day” for the millions who would be hit A

He said: ” It has been shown to be effective, well tolerated, easy to administer and supplied by the non-profit AstraZeneca A We would like to thank our many colleagues at AstraZeneca, the University of Oxford, the UK government and the dozens of thousands of clinical trial participants A

A change in vaccination strategy

The Joint Committee on Vaccination and Immunization (JCVI) will also publish its latest advice for priority groups to receive this vaccine A

He has recommended a change in strategy, prioritizing getting the first dose from as many people in risk groups as possible, rather than providing the two necessary doses in the shortest time possible A

Everyonee will get their second dose and this will be within 12 weeks of the first A The second dose completes the cycle and is important for longer term protection,” the UK government said A

He added that administering the vaccines in this way will maximize the benefits of both vaccines, according to the JCVI advice A

” It will ensure that more people at risk can get meaningful protection from a vaccine in the coming weeks and months, reducing deaths and beginning to ease the pressure on our NHS A”

The announcement came as the UK was grappling with a new variant of COVID-19, which saw many European countries close their borders to the island nation A

The new variant has now been reported in other countries on the continent, as well as the US A

style="display:block" data-ad-client="ca-pub-3066188993566428" data-ad-slot="4073357244" data-ad-format="auto" data-full-width-responsive="true">
feedproxy Agoogle Acom

Leave a Reply

Your email address will not be published. Required fields are marked *

LinkedIn
Share